The Medicines and Healthcare products Regulatory Agency (MHRA) has issued a fresh alert for people taking Ozempic, Wegovy, Rybelsus, or Mounjaro. The agency posted a message on social media urging anyone who has experienced a severe reaction to GLP-1 medicines to report it. According to the UK government’s health site, GLP-1 receptor agonists (glucagon-like peptide-1) are drugs designed to mimic a natural hormone that helps control appetite after eating. While these medicines are widely used for managing diabetes and aiding weight loss, they may also carry certain health risks.MHRA Issues Warning for Ozempic, Wegovy, Rybelsus, and Mounjaro UsersThe MHRA’s advisory highlights the importance of reporting side effects, particularly acute pancreatitis, to help researchers understand these reac

See Full Page